These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36057734)

  • 1. Application of spectral CT combined with perfusion scan in diagnosis of pancreatic neuroendocrine tumors.
    Wan Y; Hao H; Chen Y; Zhang Y; Yue Q; Li Z
    Insights Imaging; 2022 Sep; 13(1):145. PubMed ID: 36057734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors.
    Wan Y; Hao H; Meng S; Li Z; Yu F; Meng Chi ; Chao Q; Gao J
    Pancreatology; 2021 Jan; 21(1):240-245. PubMed ID: 33191144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Pathological Grades of Pancreatic Neuroendocrine Tumors Based on Dynamic Contrast-Enhanced Ultrasound Quantitative Analysis.
    Yang DH; Cheng J; Tian XF; Zhang Q; Yu LY; Qiu YJ; Lu XY; Lou WH; Dong Y; Wang WP
    Diagnostics (Basel); 2023 Jan; 13(2):. PubMed ID: 36673048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
    Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
    Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
    Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
    Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
    Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
    Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of pancreatic neuroendocrine tumors (PNET) using semi-quantitative [68Ga]DOTATOC PET in combination with multiphase contrast-enhanced CT.
    Froeling V; Röttgen R; Collettini F; Rothe J; Hamm B; Brenner W; Schreiter N
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):310-8. PubMed ID: 25265251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT texture analysis of liver metastases in PNETs versus NPNETs: Correlation with histopathological findings.
    Martini I; Polici M; Zerunian M; Panzuto F; Rinzivillo M; Landolfi F; Magi L; Caruso D; Eid M; Annibale B; Laghi A; Iannicelli E
    Eur J Radiol; 2020 Mar; 124():108812. PubMed ID: 31951893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas.
    Zeng P; Ma L; Liu J; Song Z; Liu J; Yuan H
    Eur J Radiol; 2022 May; 150():110261. PubMed ID: 35316674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Spectral and Perfusion Computed Tomography Imaging in the Differential Diagnosis of Peripheral Lung Cancer and Focal Organizing Pneumonia.
    Deng L; Zhang G; Lin X; Han T; Zhang B; Jing M; Zhou J
    Front Oncol; 2021; 11():690254. PubMed ID: 34778025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors.
    Khashab MA; Yong E; Lennon AM; Shin EJ; Amateau S; Hruban RH; Olino K; Giday S; Fishman EK; Wolfgang CL; Edil BH; Makary M; Canto MI
    Gastrointest Endosc; 2011 Apr; 73(4):691-6. PubMed ID: 21067742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of CT Perfusion Parameters of Focal Pancreatic Lesions and Data Comparison of Different Algorithms.
    Li P; Zhu L; Xue H; Liu C; Xu K; Li J; Sun T; Jin Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):80-87. PubMed ID: 28270288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of pancreatic neuroendocrine tumors (PNET) using semi-quantitative [68Ga]DOTATOC PET in combination with multiphase contrast-enhanced CT.
    Froeling V; Röttgen R; Collettini F; Rothe J; Hamm B; Brenner W; Schreiter NF
    Q J Nucl Med Mol Imaging; 2014 Jan; ():. PubMed ID: 24382374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
    Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
    Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
    Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
    Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of malignancy and prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors.
    Liu X; Chin W; Pan C; Zhang W; Yu J; Zheng S; Liu Y
    Gland Surg; 2021 Jan; 10(1):219-232. PubMed ID: 33633978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical comparison of continuous versus intermittent perfusion computed tomography computed tomography scans of the human pancreas.
    Wan Y; Chen Y; Zhang Y; Shi J; Li Z
    Quant Imaging Med Surg; 2023 May; 13(5):3279-3287. PubMed ID: 37179943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathologic and operative characteristics of patients with small nonfunctioning pancreatic neuroendocrine tumors.
    Ha S; Song KB; Hong S; Shin D; Park Y; Kwon J; Lee W; Jun E; Lee JH; Hwang DW; Kim SC
    ANZ J Surg; 2021 Jul; 91(7-8):E484-E492. PubMed ID: 34291544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.